Get started
Author

Arno C. Hessels

Observed names: A. Hessels, A.C. Hessels, Arno C Hessels, Arno Hessels
ORCID: 0000-0001-8820-5454
Observed ORCID: 0000-0001-8820-5454
OpenAlex ID: A5081009738
Review – Late toxicity of abdominal and pelvic radiotherapy for childhood cancer
2022 · Arno C. Hessels, Johannes A. Langendijk, et al. · Radiotherapy and Oncology · 19
PDF
Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients
2018 · Arno C. Hessels, Jan Stephan F. Sanders, et al. · The Journal of Allergy and Clinical Immunology In Practice · 19
PDF
Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study
2018 · Arno C. Hessels, Abraham Rutgers, et al. · PLoS ONE · 13
PDF
Clinical outcome in anti-neutrophil cytoplasmic antibody–associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor
2018 · Arno C Hessels, Janneke Tuin, et al. · Lara D. Veeken · 12
PDF
Leg muscle strength is reduced and is associated with physical quality of life in Antineutrophil cytoplasmic antibody-associated vasculitis
2019 · Arno C. Hessels, Johannes H. van der Hoeven, et al. · PLoS ONE · 7
PDF
Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer
2025 · Liesbeth J. Boersma, Arno C. Hessels, et al. · Radiotherapy and Oncology · 4
Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis
2020 · Arno C. Hessels, Jan Stephan F. Sanders, et al. · The Pharmacogenomics Journal · 3
OP0050 Gene polymorphisms of the glucocorticoid receptor and 11Β-hydroxysteroid dehydrogenase type 1 affect relevant clinical outcomes in anca associated vasculitis
2018 · A.C. Hessels, J. Tuin, et al. · Annals of the Rheumatic Diseases · 2
PDF
A planning study of proton therapy dose escalation for non-small cell lung cancer
2024 · Arno C. Hessels, Sabine Visser, et al. · Physics and Imaging in Radiation Oncology · 1
PDF
779: Risk of left ventricular dysfunction after thoracic irradiation
2024 · Umut Fidan, Arno C. Hessels, et al. · Radiotherapy and Oncology · 1
143. Azathioprine Hypersensitivity Syndrome in a Cohort of Anca-associated Vasculitis Patients
2019 · Arno Hessels, Jan Stephan Sanders, et al. · Lara D. Veeken · 1
PDF
Dose-related cardiac side effects and its impact on survival following thoracic radiotherapy: A scoping review
2026 · Umut Fidan, Arno C. Hessels, et al. · Clinical and Translational Radiation Oncology
PDF
Proton Therapy in Locally Advanced NSCLC: Decreased Side Effects and Mortality Compared to VMAT
2026 · L.V. van Dijk, R. van de Wal, et al. · International Journal of Radiation Oncology*Biology*Physics
216 Predicted Outcome Benefits of Static and Dynamic Proton Arc Therapy Compared to Intensity-Modulated Proton Therapy for Non-Small Cell Lung Cancer
2025 · Arno C. Hessels, Robin Wijsman, et al. · Radiotherapy and Oncology
897 Impact of Heart and Lung Dosimetry on RV Function in Lung and Oesophageal Cancer Patients
2025 · Arno C. Hessels, Umut Fidan, et al. · Radiotherapy and Oncology
Regarding: “Olloni A, et al. Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study”
2024 · Arno C. Hessels, Mark L. Frederiks, et al. · JTO Clinical and Research Reports
PDF
32: Cardiac effects after lung and oesophageal cancer radiotherapy
2024 · Arno C. Hessels, Umut Fidan, et al. · Radiotherapy and Oncology
MO-0470 IMPT reduces esophageal and pulmonary toxicity compared to VMAT in stage II-IV NSCLC patients
2023 · A. Hessels, R. Stoffers, et al. · Radiotherapy and Oncology
144. Geographic Differences in Clinical Presentation and Outcome of Antineutrophil Cytoplasmic Antibody- Associated Vasculitis: Role of Antibody Specificity
2019 · Arno Hessels, Jan Stephan Sanders, et al. · Lara D. Veeken
PDF
312. Leg Muscle Strength Is Reduced and Is Associated With Physical Quality of Life in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
2019 · Arno Hessels, Johannes van der Hoeven, et al. · Lara D. Veeken
PDF
Treatment outcomes in ANCA-associated vasculitis: Determinants of efficacy and toxicity
2019 · Arno C. Hessels · University of Groningen research database (University of Groningen / Centre for Information Technology)
Works count: 21
Citation count: 82
H-index: 5
I10-index: 4
Year
Topic
Type